Levina et al. provided compelling evidence for CCL11’s pivotal role in ovarian carcinoma progression, demonstrating its significant contribution to tumor cell proliferation and invasion through the CCR2-, CCR3-, and CCR5-mediated signaling pathways. This evidence concerns the gene CCR3 and neoplasm.